{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T20:15:24Z","timestamp":1777493724882,"version":"3.51.4"},"reference-count":39,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000923","name":"Australian Research Council","doi-asserted-by":"publisher","award":["FT10100185"],"award-info":[{"award-number":["FT10100185"]}],"id":[{"id":"10.13039\/501100000923","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001791","name":"Griffith University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001791","id-type":"DOI","asserted-by":"publisher"}]},{"name":"New Researcher Scheme to GF"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal for Parasitology: Drugs and Drug Resistance"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.ijpddr.2017.01.003","type":"journal-article","created":{"date-parts":[[2017,1,13]],"date-time":"2017-01-13T07:16:20Z","timestamp":1484291780000},"page":"61-70","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Investigating the antiplasmodial activity of primary sulfonamide compounds identified in open source malaria data"],"prefix":"10.1016","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8560-3406","authenticated-orcid":false,"given":"Gillian M.","family":"Fisher","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Bua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonia","family":"Del Prete","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Megan S.J.","family":"Arnold","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clemente","family":"Capasso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudiu T.","family":"Supuran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katherine T.","family":"Andrews","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sally-Ann","family":"Poulsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpddr.2017.01.003_bib1","doi-asserted-by":"crossref","first-page":"6114","DOI":"10.1016\/j.bmcl.2013.09.015","article-title":"Antimalarial activity of compounds comprising a primary benzene sulfonamide fragment","volume":"23","author":"Andrews","year":"2013","journal-title":"Bioorg Med. Chem. Lett."},{"key":"10.1016\/j.ijpddr.2017.01.003_bib2","doi-asserted-by":"crossref","first-page":"4361","DOI":"10.1128\/AAC.02948-15","article-title":"Adaptation of the [3H]Hypoxanthine uptake assay for in\u00a0vitro-cultured Plasmodium knowlesi malaria parasites","volume":"60","author":"Arnold","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2017.01.003_bib3","doi-asserted-by":"crossref","first-page":"D539","DOI":"10.1093\/nar\/gkn814","article-title":"PlasmoDB: a functional genomic database for malaria parasites","volume":"37","author":"Aurrecoechea","year":"2009","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ijpddr.2017.01.003_bib4","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1093\/cid\/cis902","article-title":"A\u00a0prospective comparative study of knowlesi, falciparum, and vivax malaria in Sabah, Malaysia: high proportion with severe disease from Plasmodium knowlesi and Plasmodium vivax but no mortality with early referral and artesunate therapy","volume":"56","author":"Barber","year":"2013","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ijpddr.2017.01.003_bib5","doi-asserted-by":"crossref","first-page":"814","DOI":"10.3201\/eid1705.101489","article-title":"Plasmodium knowlesi malaria in children","volume":"17","author":"Barber","year":"2011","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.ijpddr.2017.01.003_bib6","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1517\/13543776.2013.778245","article-title":"Anti-infective carbonic anhydrase inhibitors: a patent and literature review","volume":"23","author":"Capasso","year":"2013","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.ijpddr.2017.01.003_bib7","doi-asserted-by":"crossref","first-page":"e0149996","DOI":"10.1371\/journal.pone.0149996","article-title":"Biochemical screening of five protein kinases from Plasmodium falciparum against 14,000 cell-active compounds","volume":"11","author":"Crowther","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.ijpddr.2017.01.003_bib8","doi-asserted-by":"crossref","first-page":"4389","DOI":"10.1016\/j.bmcl.2014.08.015","article-title":"Discovery of a new family of carbonic anhydrases in the malaria pathogen Plasmodium falciparum\u2013the eta-carbonic anhydrases","volume":"24","author":"Del Prete","year":"2014","journal-title":"Bioorg Med. Chem. Lett."},{"key":"10.1016\/j.ijpddr.2017.01.003_bib9","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.EI10-0013-2016","article-title":"Artemisinin-resistant Plasmodium falciparum malaria","volume":"4","author":"Fairhurst","year":"2016","journal-title":"Microbiol. Spectr."},{"key":"10.1016\/j.ijpddr.2017.01.003_bib10","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1476-5381.1951.tb00634.x","article-title":"2:4-diaminopyrimidines- a new series of antimalarials","volume":"6","author":"Falco","year":"1951","journal-title":"Br. J. Pharmacol. Chemother."},{"key":"10.1016\/j.ijpddr.2017.01.003_bib11","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1111\/cbdd.12335","article-title":"Synthesis and evaluation of antimalarial properties of novel 4-aminoquinoline hybrid compounds","volume":"84","author":"Fisher","year":"2014","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.ijpddr.2017.01.003_bib12","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/nature09107","article-title":"Thousands of chemical starting points for antimalarial lead identification","volume":"465","author":"Gamo","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.ijpddr.2017.01.003_bib13","doi-asserted-by":"crossref","first-page":"D1100","DOI":"10.1093\/nar\/gkr777","article-title":"ChEMBL: a large-scale bioactivity database for drug discovery","volume":"40","author":"Gaulton","year":"2012","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ijpddr.2017.01.003_bib14","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1093\/jac\/30.4.417","article-title":"The quinine connection","volume":"30","author":"Greenwood","year":"1992","journal-title":"J.\u00a0Antimicrob. Chemother."},{"key":"10.1016\/j.ijpddr.2017.01.003_bib15","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1124\/pr.57.1.4","article-title":"Mechanisms of resistance of malaria parasites to antifolates","volume":"57","author":"Gregson","year":"2005","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ijpddr.2017.01.003_bib16","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/0001-706X(93)90083-N","article-title":"A\u00a0comparison of three methods of estimating EC50 in studies of drug resistance of malaria parasites","volume":"55","author":"Huber","year":"1993","journal-title":"Acta Trop."},{"key":"10.1016\/j.ijpddr.2017.01.003_bib17","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.3201\/eid1710.110349","article-title":"Plasmodium knowlesi Malaria in humans and macaques","volume":"17","author":"Jongwutiwes","year":"2011","journal-title":"Thail. Emerg. Infect. Dis."},{"key":"10.1016\/j.ijpddr.2017.01.003_bib18","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.3201\/eid1012.040293","article-title":"Naturally acquired Plasmodium knowlesi malaria in human","volume":"10","author":"Jongwutiwes","year":"2004","journal-title":"Thail. Emerg. Infect. Dis."},{"key":"10.1016\/j.ijpddr.2017.01.003_bib19","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1093\/cid\/cir180","article-title":"Review of cases with the emerging fifth human malaria parasite, Plasmodium knowlesi","volume":"52","author":"Kantele","year":"2011","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ijpddr.2017.01.003_bib20","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1016\/S0021-9258(18)62326-9","article-title":"The carbon dioxide hydration activity of carbonic anhydrase. I. Stop-flow kinetic studies on the native human isoenzymes B and C","volume":"246","author":"Khalifah","year":"1971","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ijpddr.2017.01.003_bib21","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.3201\/eid1710.110355","article-title":"Plasmodium knowlesi infection in humans, Cambodia, 2007-2010","volume":"17","author":"Khim","year":"2011","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.ijpddr.2017.01.003_bib22","doi-asserted-by":"crossref","first-page":"5466","DOI":"10.1016\/j.bmcl.2008.09.030","article-title":"Carbonic anhydrase inhibitors: inhibition of Plasmodium falciparum carbonic anhydrase with aromatic\/heterocyclic sulfonamides-in\u00a0vitro and in\u00a0vivo studies","volume":"18","author":"Krungkrai","year":"2008","journal-title":"Bioorg Med. Chem. Lett."},{"issue":"Suppl.\u00a02","key":"10.1016\/j.ijpddr.2017.01.003_bib23","first-page":"32","article-title":"Molecular biology and biochemistry of malarial parasite pyrimidine biosynthetic pathway","volume":"34","author":"Krungkrai","year":"2003","journal-title":"Southeast Asian J. Trop. Med. Public Health"},{"key":"10.1016\/j.ijpddr.2017.01.003_bib24","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/1475-2875-12-88","article-title":"Hyperparasitaemic human Plasmodium knowlesi infection with atypical morphology in peninsular Malaysia","volume":"12","author":"Lee","year":"2013","journal-title":"Malar. J."},{"key":"10.1016\/j.ijpddr.2017.01.003_bib25","doi-asserted-by":"crossref","first-page":"811","DOI":"10.3201\/eid1405.071407","article-title":"Human infections with Plasmodium knowlesi, the Philippines","volume":"14","author":"Luchavez","year":"2008","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.ijpddr.2017.01.003_bib26","unstructured":"Medicines for Malaria Venture (MMV) http:\/\/www.mmv.org\/research-development\/interactive-rd-portfolio, (Accessed 26 November 2016)."},{"key":"10.1016\/j.ijpddr.2017.01.003_bib27","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1073\/pnas.1216457110","article-title":"Adaptation of the genetically tractable malaria pathogen Plasmodium knowlesi to continuous culture in human erythrocytes","volume":"110","author":"Moon","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ijpddr.2017.01.003_bib28","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S1471-4922(03)00028-X","article-title":"Malaria drug-sensitivity testing: new assays, new perspectives","volume":"19","author":"Noedl","year":"2003","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.ijpddr.2017.01.003_bib29","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.semcancer.2014.08.002","article-title":"Hypoxia-induced carbonic anhydrase IX as a target for cancer therapy: from biology to clinical use","volume":"31","author":"Pastorek","year":"2015","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.ijpddr.2017.01.003_bib30","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1517\/13543776.2010.484803","article-title":"Carbonic anhydrase inhibition as a cancer therapy: a review of patent literature, 2007-2009","volume":"20","author":"Poulsen","year":"2010","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.ijpddr.2017.01.003_bib31","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0306-9877(98)90172-4","article-title":"The pivotal role of carbonic anhydrase in malaria infection","volume":"50","author":"Sein","year":"1998","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.ijpddr.2017.01.003_bib32","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/nrd2467","article-title":"Carbonic anhydrases: novel therapeutic applications for inhibitors and activators","volume":"7","author":"Supuran","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ijpddr.2017.01.003_bib33","doi-asserted-by":"crossref","first-page":"3467","DOI":"10.1016\/j.bmcl.2010.05.009","article-title":"Carbonic anhydrase inhibitors","volume":"20","author":"Supuran","year":"2010","journal-title":"Bioorg Med. Chem. Lett."},{"key":"10.1016\/j.ijpddr.2017.01.003_bib34","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.4155\/fmc.15.71","article-title":"Carbonic anhydrase IX inhibitors in cancer therapy: an update","volume":"7","author":"Supuran","year":"2015","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.ijpddr.2017.01.003_bib35","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.bmc.2014.12.009","article-title":"Sulfonamide inhibition studies of the eta-class carbonic anhydrase from the malaria pathogen Plasmodium falciparum","volume":"23","author":"Vullo","year":"2015","journal-title":"Bioorg Med. Chem."},{"key":"10.1016\/j.ijpddr.2017.01.003_bib36","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/nrd4573","article-title":"Malaria medicines: a glass half full?","volume":"14","author":"Wells","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ijpddr.2017.01.003_bib37","series-title":"World Malaria Report, 2015","author":"WHO","year":"2015"},{"key":"10.1016\/j.ijpddr.2017.01.003_bib38","first-page":"33","article-title":"Malaria vaccine: WHO position paper-January 2016","volume":"91","author":"WHO","year":"2016","journal-title":"Wkly. Epidemiol. Rec."},{"key":"10.1016\/j.ijpddr.2017.01.003_bib39","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.3201\/eid.1707.101017","article-title":"Severe Plasmodium knowlesi malaria in a tertiary care hospital, Sabah, Malaysia","volume":"17","author":"William","year":"2011","journal-title":"Emerg. Infect. Dis."}],"container-title":["International Journal for Parasitology: Drugs and Drug Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211320716301269?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211320716301269?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T14:46:47Z","timestamp":1761922007000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211320716301269"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["S2211320716301269"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpddr.2017.01.003","relation":{},"ISSN":["2211-3207"],"issn-type":[{"value":"2211-3207","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Investigating the antiplasmodial activity of primary sulfonamide compounds identified in open source malaria data","name":"articletitle","label":"Article Title"},{"value":"International Journal for Parasitology: Drugs and Drug Resistance","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpddr.2017.01.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Authors. Published by Elsevier Ltd on behalf of Australian Society for Parasitology.","name":"copyright","label":"Copyright"}]}}